The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Share News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,742.00
Bid: 0.00
Ask: 1,830.00
Change: 0.00 (0.00%)
Spread: 91.00 (5.233%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,742.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXTRA: Sterling Weakness Boosts Johnson Matthey First Quarter Sales

Wed, 20th Jul 2016 10:02

LONDON (Alliance News) - Platinum and chemicals company Johnson Matthey PLC affirmed on Wednesday its expectations for its full financial year after revenue across its divisions was boosted by a weaker pound which helped to offset mixed constant currency trading.

The FTSE 100 constituent, which makes emission control systems, catalysts and fine chemicals, said sales grew 6.0% year-on-year in its first quarter to the end of June. In constant currencies, sales rose just 2.0% as sales at actual rates benefited from the strength of the dollar against sterling.

Johnson Matthey said underlying profit, in constant currencies and stripping out one-off acquisition and restructuring-related charges, was broadly in line year-on-year in the quarter. It continues to expect its results for the 2017 financial year will outpace the previous year, albeit weighted to the second half.

If current exchange rates remain as they are, in particular with the pound weak against the dollar following the UK's vote to leave the European Union, the group said it expects it will get a translational boost to profit for the full year.

Johnson Matthey said its full-year outlook in constant currencies remains unchanged. It added that, while too early to forecast the long-term impact of Brexit, it does not believe the UK leaving the EU will have a significant effect on its business, and its strategic plans are unchanged.

Shares in Johnson Matthey were up 1.1% to 3,183.00 pence Wednesday.

Emission Control Technologies was the star performer in the quarter, with sales up 9.0% year-on-year. Light duty vehicle catalyst sales grew 14% year-on-year, driven by growth in all regions but a particularly strong period in Europe helped by robust car production volumes in key markets.

Heavy duty catalyst sales were more subdued, up 1.0% and down 5.0% in constant currencies. A slowdown in demand for Class 8 trucks in North American held back sales growth and production of these trucks continued to weaken through the quarter, though Johnson Matthey still expects this segment to stabilise later in its financial year. Heavy duty sales in Europe were strong, helped by good growth in truck production in western Europe.

Sales for the Process Technologies division, which supplies catalysts and absorbents to the petrochemical, oil refining and gas processing industries, grew 3.0% but fell 1.0% in constant currencies. Growth in sales to chemical industry customers helped to offset soft demand for the group's oil and gas businesses, Johnson Matthey said.

Chemical sales were boosted by good demand for specialty products in the petrochemicals sector, which offset weakness in technology licensing activity. Oil and gas demand was weaker against a strong comparator for the year prior and as market conditions remained tough in the industry.

Precious Metal Products, where the company refines and recycles precious metals into new products, saw revenue grow 6.0% in the quarter and by 1.0% in constant currencies. Sales increased for Johnson Matthey's Precious Metals Management unit due to volatility in platinum group metals prices in the quarter, while intake volumes for its refining and recycling business were stable.

Sales in the manufacturing unit within Precious Metal Products were slightly lower, with a weaker first quarter for Noble Metals, partly offset by better demand for Advanced Glass Technologies.

In the Fine Chemicals arm, sales in the quarter were flat and fell 5.0% in constant currencies. Active pharmaceutical ingredient sales were slightly down due to order timings, but the Catalysis and Chiral Technologies benefited from strong demand for homogeneous catalysts.

Johnson Matthey's other unit, New Businesses, saw sales rise 14% and by 11% in constant currencies. The division, which houses new areas of interest adjacent to the company's existing operations, saw good demand for battery materials and contributions from the Water Technologies acquisitions the firm made in April and May.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 09:26

LONDON BROKER RATINGS: Peel Hunt starts NatWest and Barclays at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
10 Apr 2024 08:41

Johnson Matthey and BP win deal for US sustainable aviation fuel plant

(Alliance News) - Johnson Matthey PLC and BP PLC on Wednesday said their technology offering has been selected for use in a sustainable aviation fuel plant being built in the US state of Louisiana.

Read more
10 Apr 2024 07:47

LONDON BRIEFING: Stocks called up ahead of US inflation data

(Alliance News) - Stocks in London are called to open higher, as investors shake off nerves ahead of a key US inflation reading.

Read more
9 Apr 2024 09:51

Berenberg hikes target price on Johnson Matthey

(Sharecast News) - Analysts at Berenberg raised their target price on diversified chemicals business Johnson Matthey from 1,650.0p to 1,800.0p on Tuesday but said the performance of its shares will likely depend on three factors.

Read more
9 Apr 2024 08:54

LONDON BROKER RATINGS: Barclays raises Halma to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
9 Apr 2024 07:39

LONDON BRIEFING: HSBC sells Argentinian arm for USD550 million

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors nervously look ahead to US inflation data and the European Central Bank's latest interest rate decision.

Read more
25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
20 Mar 2024 16:54

LONDON MARKET CLOSE: FTSE 100 treads water while Kering weighs on CAC

(Alliance News) - London's FTSE 100 finished the day largely as it started it, enduring an uninspiring session on Wednesday, with the latest Federal Reserve decision about an hour away.

Read more
20 Mar 2024 16:53

London close: Stocks mixed ahead of Fed, BoE decisions

(Sharecast News) - London markets closed with a mixed but little-changed performance on Wednesday, as investors digested a larger-than-expected slowdown in UK inflation.

Read more
20 Mar 2024 11:49

LONDON MARKET MIDDAY: Pre-Fed rate nerves push FTSE 100 in red

(Alliance News) - The FTSE 100 was in the red on Wednesday at midday, as relief from cooling UK inflation was not enough to shake off nerves ahead of the latest US Federal Reserve interest rate decision.

Read more
20 Mar 2024 08:45

LONDON MARKET OPEN: UK inflation cooler than expected ahead of BoE

(Alliance News) - The FTSE 100 in London opened lower on Wednesday morning, with cooler-than-expected inflation doing little to shake off pre-US Federal rate nerves.

Read more
20 Mar 2024 08:32

Johnson Matthey sells medical device components arm for USD700 million

(Alliance News) - Johnson Matthey PLC on Wednesday said it has agreed to sell its Medical Device Components business to Montagu Private Equity LLP, with the proceeds to fund a share buyback.

Read more
20 Mar 2024 07:40

LONDON BRIEFING: UK inflation cools to 3.4% in February; Eyes on Fed

(Alliance News) - Stocks in London are expected to open slightly lower on Wednesday, as investors digest some cooler-than-expected inflation in the UK and look ahead to the latest US interest rate decision.

Read more
20 Mar 2024 07:08

Johnson Matthey sells medical parts unit for $700m

(Sharecast News) - Johnson Matthey is selling its medical device components business to Montagu Private Equity for $700m (£550m), the company said on Wednesday.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.